Drug
RE104 for Injection
RE104 for Injection is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_2
3
75%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
recruiting125%
completed250%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
NCT07002034
not_yet_recruitingphase_2
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
NCT07489651
completedphase_2
RE104 Safety and Efficacy Study in Postpartum Depression
NCT06342310
completedphase_1
RE104 Clinical Lactation Study
NCT06659263
Clinical Trials (4)
Showing 4 of 4 trials
NCT07002034Phase 2
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
NCT07489651Phase 2
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
NCT06342310Phase 2
RE104 Safety and Efficacy Study in Postpartum Depression
NCT06659263Phase 1
RE104 Clinical Lactation Study
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4